Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03528408
Title Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Suthee Rapisuwon
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94158 United States Details
Georgetown University Washington District of Columbia 20057 United States Details
Northwestern Univeristy Feinberg School of Medicine Chicago Illinois 60611 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Columbia University New York New York 10032 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field